C90.02
Multiple myeloma in relapse
Clinical Classification Guidelines
Medical Intelligence & Overview
Multiple myeloma is a type of blood cancer that originates in the plasma cells of the bone marrow. When it relapses, it means that after a period of remission or improvement, the disease has returned or worsened. The ICD-10 code C90.02 specifically identifies cases where multiple myeloma has relapsed, signifying an ongoing challenge in management and treatment. Recognizing the signs, causes, and treatment options is crucial for affected individuals and their healthcare providers.
Causes & Symptoms
Clinical Causes: Incomplete eradication of cancer cells during initial treatment Genetic mutations leading to resistant cancer cell clones Changes in the bone marrow microenvironment that support tumor growth Previous exposure to chemotherapy or radiation therapy reducing the effectiveness of treatments Progression of the disease despite ongoing therapy
Key Symptoms: Bone pain, especially in the back, ribs, or skull Fatigue and weakness Unintentional weight loss Signs of anemia such as pallor and shortness of breath Elevated calcium levels causing confusion, constipation, or dehydration Recurrent infections due to compromised immune function Swelling or bleeding tendencies
Diagnostic & Treatment
Diagnosis Path: The diagnosis of multiple myeloma relapse involves several steps:
Treatment Protocols: Treating relapsed multiple myeloma aims to control symptoms, reduce tumor burden, and improve quality of life. Options include:
Clinical Advice & FAQs
Billing Guidance
Is C90.02 a billable ICD-10 code?
Yes, C90.02 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C90.02?
Clinical documentation must specify the nature of Multiple myeloma in relapse and any associated comorbidities for accurate reporting.
Cite this Clinical Reference